Bing Zhu

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Diego Cadavid, Michelle Mellion, Raymond Hupperts et al. · The Lancet Neurology · 2019 · 173 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +5

Relationship between amide proton chemical shifts and hydrogen bonding in amphipathic .alpha.-helical peptides

Nian Zhou, Bing Zhu, Brian D. Sykes et al. · Journal of the American Chemical Society · 1992 · 156 citations

Biochemistry, Protein Folding, Natural Sciences +13

Metabolism And Excretion of the Dipeptidyl Peptidase 4 Inhibitor [14C]Sitagliptin in Humans

Stella Vincent, James R. Reed, Arthur Bergman et al. · Drug Metabolism and Disposition · 2007 · 148 citations

St John's wort induces both cytochrome P450 3A4–catalyzed sulfoxidation and 2C19–dependent hydroxylation of omeprazole

Liansheng Wang, Gan Zhou, Bing Zhu et al. · Clinical Pharmacology & Therapeutics · 2004 · 144 citations

(2<i>S</i>,3<i>S</i>)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-<i>N,N</i>-dimethyl-4-oxo-2-(4-[1,2,4]triazolo[1,5-<i>a</i>]- pyridin-6-ylphenyl)butanamide:  A Selective α-Amino Amide Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

Scott D. Edmondson, Anthony Mastracchio, Robert J. Mathvink et al. · Journal of Medicinal Chemistry · 2006 · 121 citations · Full text